Inventor · disambiguated record
Andrew Peter Thomas
Also filed as: THOMAS ANDREW · THOMAS ANDREW P · THOMAS ANDREW PETER
48 granted patents·19 pending applications·1,760 citations·filing 1992–2021
99Inventor score
Top patents by PatentIndex Score
67 records- 0197US6362336B1Chemical compoundsZENECA LTD·Filed 2001·Granted Mar 26, 2002·115 cites·1 claims
- 0296US7087602B2Cinnoline derivatives and use as medicineASTRAZENECA UK LTD·Filed 2002·Granted Aug 8, 2006·50 cites·10 claims
- 0396US6514971B1Cinnoline derivatives and use as medicineZENECA LTD·Filed 1997·Granted Feb 4, 2003·84 cites·13 claims
- 0496US6258951B1Chemical compoundsZENECA LTD·Filed 2000·Granted Jul 10, 2001·72 cites·1 claims
- 0596US5962458ASubstituted quinazolinesZENECA LTD·Filed 1996·Granted Oct 5, 1999·156 cites·14 claims
- 0695US6908920B2Pyrimidine derivativesASTRAZENECA AB·Filed 2001·Granted Jun 21, 2005·124 cites·10 claims
- 0795US6673803B2Quinazoline derivatives and pharmaceutical compositions containing themZENECA LTD·Filed 2002·Granted Jan 6, 2004·68 cites·13 claims
- 0894US6809097B1Quinoline derivatives inhibiting the effect of growth factors such as VEGFZENECA LTD·Filed 1997·Granted Oct 26, 2004·76 cites·24 claims
- 0993US6414148B1Quinazoline derivatives and pharmaceutical compositions containing themZENECA LTD·Filed 1997·Granted Jul 2, 2002·96 cites·23 claims
- 1092US7737149B2N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereofASTRAZENECA AB·Filed 2007·Granted Jun 15, 2010·17 cites·3 claims
- 1192US5821246AAniline derivativesZENECA LTD·Filed 1995·Granted Oct 13, 1998·128 cites·13 claims
- 1291US6184225B1Quinazoline derivatives as VEGF inhibitorsZENECA LTD·Filed 1997·Granted Feb 6, 2001·112 cites·18 claims
- 1390US8129391B2N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereofFOOTE KEVIN MICHAEL·Filed 2010·Granted Mar 6, 2012·12 cites·3 claims
- 1490US7173038B1Quinazoline derivatives as VEGF inhibitorsASTRAZENECA AB·Filed 2000·Granted Feb 6, 2007·24 cites·11 claims
- 1590US6855719B1Imidazo[1,2-A]pyridine and pyrazolo[2,3-A]pyridine derivativesASTRAZENECA AB·Filed 2000·Granted Feb 15, 2005·90 cites·12 claims
- 1689US6265411B1Oxindole derivativesZENECA LTD·Filed 1997·Granted Jul 24, 2001·95 cites·19 claims
- 1788US6294532B1Oxindolylquinazoline derivatives as angiogenesis inhibitorsZENECA LTD·Filed 1998·Granted Sep 25, 2001·87 cites·23 claims
- 1888US6071921AChemical compoundsZENECA LTD·Filed 1998·Granted Jun 6, 2000·58 cites·13 claims
- 1987US8604022B2N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereofFOOTE KEVIN MICHAEL·Filed 2012·Granted Dec 10, 2013·8 cites·4 claims
- 2086US6897210B2Quinazoline derivatives and pharmaceutical compositions containing themZENECA PHARMA SA·Filed 2003·Granted May 24, 2005·26 cites·6 claims
- 2183US7579349B24-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancerASTRAZENECA AB·Filed 2004·Granted Aug 25, 2009·19 cites·33 claims
- 2283US6969714B2Imidazolo-5-YL-2-anilino-pyrimidines as agents for the inhibition of the cell proliferationASTRAZENECA AB·Filed 2001·Granted Nov 29, 2005·18 cites·15 claims
- 2383US6291455B14-anilinoquinazoline derivativesZENECA LTD·Filed 1997·Granted Sep 18, 2001·56 cites·12 claims
- 2482US6844341B2Pyrimidine derivatives for inhibition of cell proliferationASTRAZENECA AB·Filed 2002·Granted Jan 18, 2005·17 cites·16 claims
- 2581US9688640B2Methods of treating cancer with a pyrazole derivativeASTRAZENECA AB·Filed 2015·Granted Jun 27, 2017·2 cites·3 claims
- 2680US7521453B2Pyrimidine derivatives as modulators of insulin-like growth factor-1 receptor (IGF-I)ASTRAZENECA AB·Filed 2002·Granted Apr 21, 2009·18 cites·18 claims
- 2779US2020262811A1Quinazoline Derivatives as VEGF InhibitorsGENZYME CORP·Filed 2019·Application pending·0 cites
- 2877US9040548B2Quinazoline derivatives as VEGF inhibitorsASTRAZENECA AB·Filed 2014·Granted May 26, 2015·1 cites·6 claims
- 2977US6906065B24-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinasesASTRAZENECA AB·Filed 2001·Granted Jun 14, 2005·10 cites·11 claims
- 3076US2021276972A1Quinazoline Derivatives as VEGF InhibitorsGENZYME CORP·Filed 2021·Application pending·0 cites
- 3175US6939872B22-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitorsASTRAZENECA AB·Filed 2002·Granted Sep 6, 2005·9 cites·12 claims
- 3275US5334718AChemical process and intermediates used thereinZENECA LTD·Filed 1993·Granted Aug 2, 1994·17 cites·11 claims
- 3374US8642608B2Quinazoline derivatives as VEGF inhibitorsTHOMAS ANDREW PETER·Filed 2010·Granted Feb 4, 2014·2 cites·11 claims
- 3474US5294716AChemical process for making angiotesin II antagonist compoundsICI PLC·Filed 1992·Granted Mar 15, 1994·15 cites·9 claims
- 3570US7485638B2Pyrimidine compoundsASTRAZENECA AB·Filed 2003·Granted Feb 3, 2009·4 cites·12 claims
- 3669US10457664B2Quinazoline derivatives as VEGF inhibitorsGENZYME CORP·Filed 2017·Granted Oct 29, 2019·0 cites·14 claims
- 3769US5387592ASubstituted benzoxazole, benzthiazole, and benzimidazole derivatives as angiotensin II antagonistsICI PLC·Filed 1992·Granted Feb 7, 1995·23 cites·10 claims
- 3867US7465728B2Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activityASTRAZENECA AB·Filed 2003·Granted Dec 16, 2008·3 cites·19 claims
- 3965US2018099946A1Quinazoline Derivatives as VEGF InhibitorsGENZYME CORP·Filed 2017·Application pending·0 cites
- 4064US10301267B2CompoundsASTRAZENECA AB·Filed 2017·Granted May 28, 2019·0 cites·2 claims
- 4164US2007265286A1Quinazoline derivatives as VEGF inhibitorsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 4263US7427626B22-Anilino-4-(imidazol-5-yl)-pyrimidine derivatives and their use as cdk (cdk2) inhibitorsASTRAZENECA AB·Filed 2004·Granted Sep 23, 2008·1 cites·14 claims
- 4362USRE42353EQuinazoline derivatives and pharmaceutical compositions containing themASTRAZENECA UK LTD·Filed 1997·Granted May 10, 2011·13 cites·23 claims
- 4462US7446105B2Pyrimidine compoundsASTRAZENECA AB·Filed 2003·Granted Nov 4, 2008·1 cites·12 claims
- 4562US7442697B24-imidazolyl substituted pyrimidine derivatives with CDK inhibitory activityASTRAZENECA AB·Filed 2003·Granted Oct 28, 2008·1 cites·11 claims
- 4662US2014066455A1Novel compoundsASTRAZENECA AB·Filed 2013·Application pending·0 cites
- 4760US8697696B2Triazole compounds IIGABRIEL STEPHEN DEEMS·Filed 2011·Granted Apr 15, 2014·1 cites·29 claims
- 4860US7579344B2Pyrimidine derivatives possessing cell-cycle inhibitors activityASTRAZENECA AB·Filed 2004·Granted Aug 25, 2009·1 cites·14 claims
- 4959US2009131463A1Novel compoundsASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 5059US2016130249A1Quinazoline Derivatives as VEGF InhibitorsASTRAZENECA AB·Filed 2015·Application pending·0 cites
Showing the top 50 of 67 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Andrew Peter Thomas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →